Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 1/2 1

Status

Completed 9Withdrawn 2Terminated 2Recruiting 2Unknown 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Rectal Neoplasms 5Lung Neoplasms 5Carcinoma, Non-Small-Cell Lung 5Colorectal Neoplasms 4Central Nervous System Neoplasms 4Breast Neoplasms 3Uterine Cervical Neoplasms 2Sarcoma 2Pancreatic Neoplasms 2Osteosarcoma 2Lymphoma 2Gliosarcoma 2Glioblastoma 2Colonic Neoplasms 2Vomiting 1Radiation Injuries 1Peritoneal Neoplasms 1Ovarian Neoplasms 1Neuroectodermal Tumors, Primitive, Peripheral 1Neoplasm Metastasis 1Nausea 1Nasopharyngeal Carcinoma 1Mouth Neoplasms 1Lymphoma, Follicular 1Kidney Neoplasms 1Hodgkin Disease 1Fallopian Tube Neoplasms 1Esophageal Neoplasms 1Cardiotoxicity 1Carcinoma, Renal Cell 1

Interventions

Gemcitabine 100130-nm albumin-bound paclitaxel 34Oxaliplatin 28Capecitabine 27Fluorouracil 25Albumin-Bound Paclitaxel 23Leucovorin 19Irinotecan 18Erlotinib Hydrochloride 14Cyclophosphamide 12Radiosurgery 11pembrolizumab 10Radiotherapy 10Nivolumab 10Bevacizumab 10Surgical Procedures, Operative 9avelumab 7Docetaxel 7Taxes 6Cisplatin 6ruxolitinib 5folfirinox 5Specimen Handling 5Paclitaxel 5Everolimus 5Cetuximab 5ALT-803 5trametinib 4spartalizumab 4fludarabine 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × Pancreatic Neoplasms × Chemotherapy, Adjuvant × Clear all
NCT01314027 2019-07-25

Adjuvant Versus Neoadjuvant Plus Adjuvant Chemotherapy in Resectable Pancreatic Cancer

University of Zurich

Phase 3 Terminated
38 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT00410774 2012-09-17

Gemcitabine and Bevacizumab in Treating Patients With Pancreatic Cancer That Has Been Completely Removed By Surgery

University of California, San Francisco

Phase 1/2 Terminated
20 enrolled
Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡